FANCI Antibody Summary
| Immunogen |
A synthetic peptide mapping to a region between residues 200 and 250 of human KIAA1794/FLJ10719 using the numbering given in TrEMBL entry Q9NVI1 (GeneID 55215).
|
| Clonality |
Polyclonal
|
| Host |
Rabbit
|
| Gene |
FANCI
|
| Purity |
Immunogen affinity purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
||
| Application Notes |
This antibody can be used for Western Blot. *The investigator should determine the optimal working dilution for a specific application.
|
||
| Positive Control |
|
||
| Publications |
|
Reactivity Notes
Human
Packaging, Storage & Formulations
| Storage |
Store at 4C. Do not freeze.
|
| Buffer |
Tris-Citrate/Phosphate (pH 7.0 – 8.0)
|
| Preservative |
0.09% Sodium Azide
|
| Concentration |
1.0 mg/ml
|
| Purity |
Immunogen affinity purified
|
Alternate Names for FANCI Antibody
- Fanconi anemia group I protein
- Fanconi anemia, complementation group I
- KIAA1794FLJ10719
- Protein FACI
Background
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group I. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq]